Chinese and French scientists win Shaw Prize for leukaemia cure
⏮ BeforeThe rare form of leukaemia was often deadly.
✅ NowIt is now widely curable, according to the researchers' work.
In short
- The 2026 Shaw Prize in Life Science and Medicine went to Chinese and French winners.
- Their research turned a rare form of leukaemia from deadly to widely curable.
- The award was presented at a ceremony in Hong Kong attended by Chief Executive John Lee Ka-chiu.
Why it's good news
The winners describe their work as an East meets West collaboration across borders. The prize recognises research that changed a disease once usually fatal. The source does not give the number of patients affected or the exact treatment details.
Advertisement
From South China Morning Post
The Chinese and French winners of the 2026 Shaw Prize in Life Science and Medicine have highlighted the spirit of “borderless connections” and friendship behind their research – which turned a rare form of leukaemia from deadly to widely curable. At an awards ceremony at the Hong Kong Convention and Exhibition Centre on Tuesday attended by Chief Executive John Lee Ka-chiu, the life scientists celebrated their breakthrough as an “East meets West” success story and called for collaboration to...
Ask this story
More like this
Advertisement